Asia-Pacific Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type), End User (Hospitals, Diagnostic and Research Laboratories), and Country

The Asia Pacific colorectal cancer market was valued at US$ 3,313.9 million in 2019 and is projected to reach US$ 4,900.6 million by 2027; it is expected to grow at a CAGR of 4.5% from 2020 to 2027.

The growth of the Asia Pacific colorectal cancer market is primarily ascribed to the increasing prevalence of colorectal cancer, rising number of new product launches, and benefits of generic drugs. On the other hand, pricing pressure on drug manufacturers is restraining the growth of the market. In contrast, growth of emerging markets in developing countries is expected to have a fuel the Asia Pacific colorectal cancer market in the coming years.

Colorectal cancer is one of the commonly found and lethal cancers caused through a combined influence of genetic and environmental factors, and it affects colon, bowel, and rectum. It is the second-leading cause of death in women and third in men. Colorectal cancer may be benign, malignant, or non-cancerous. The symptoms shown by the people suffering from colon cancer include changes in bowel habits, including diarrhea or constipation, and blood in stools that makes it appear black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.

Cancer has been a leading cause of deaths in Japan since several decades. The Japanese government has been formulating and laying down multiple initiatives and programs to enhance the quality of cancer treatment and increase awareness regarding cancer in the country. In December 2015, it formulated the "Acceleration plan for cancer control." In November 2016, a bill was submitted to revise a part of the Cancer Control Act, which was enacted and implemented in December. In December 2016, the Genome Medical Forum 2016 was organized to provide an opportunity to reconstruct the cancer medical system.

The cases of cancer have significantly increased in Japan in the recent years. As per the data obtained by the WHO, ~883,395 new cancer cases were detected in 2018, with ~409,399 due to the same in that years. Among men, the prevalence of colorectum, lung, stomach, prostate, and bladder cancers was significantly high. On the other hand, among women, breast, colorectum, and lung cancers were detected in large numbers. In spite of the available options, participation is as low as 35% of the target population for both forms of cancer. The increasing prevalence of cancer, coupled with available options for screening, is expected to fuel the growth of the colorectal cancer market in Asia Pacific at a significant pace during the forecast period.

In 2019, the diagnosis segment accounted for the largest share of the Asia Pacific colorectal cancer market based on type. The growth of the market for this segment is attributed to rising number of colorectal cancer screening programs and initiatives across the world. The diagnosis segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological developments that are enabling the early detection of this cancer through various screening methods.

In 2019, the hospitals segment held the most significant share of the colorectal cancer market, by the end user. This segment is also anticipated to hold a considerable portion of the market by 2027 owing to the need for hospitals as primary healthcare centers for the people. The segment is also anticipated to register significant CAGR in the market during the forecast period.

A few of the prime secondary sources studied for preparing the colorectal cancer market report are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), and American Cancer Society.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific colorectal cancer market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
• 1.3.1 Asia-Pacific Colorectal Cancer Market - By Modality
• 1.3.2 Asia-Pacific Colorectal Cancer Market - By End User
• 1.3.3 Asia-Pacific Colorectal Cancer Market - By Country

2. Asia-Pacific Colorectal Cancer Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia-Pacific Colorectal Cancer Market - Market Landscape

• 4.1 overview
• 4.2 PEST Analysis
• 4.2.1 Colorectal Cancer Market - Asia Pacific PEST Analysis
• 4.3 Expert Opinion

5. Asia-Pacific Colorectal Cancer Market - Key Market Dynamics

• 5.1 Key Market Drivers
• 5.1.1 Increasing Prevalence Of Colorectal Cancer
• 5.1.2 New Product Launches
• 5.1.3 Benefits Offered by Generic Drugs
• 5.2 Key Restraints
• 5.2.1 Pricing Pressure On Drug Manufacturers
• 5.3 Key Market Opportunities
• 5.3.1 Emerging Markets in Developing Countries
• 5.4 Future Trend
• 5.4.1 Inclination Towards Personalized Medicine
• 5.5 Impact Analysis

6. Colorectal Cancer Market - Asia-Pacific Analysis

• 6.1 Asia-Pacific Colorectal Cancer Market Revenue Forecasts and Analysis
• 6.2 Positioning Of Key Players

7. Asia-Pacific Colorectal Cancer Market Analysis and Forecasts to 2027 - Modality

• 7.1 Overview
• 7.2 Asia-Pacific Colorectal Cancer Market, By Modality 2018 & 2027 (%)
• 7.2.1 Asia-Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 7.2.1.1 Asia-Pacific Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 7.2.1.2 Asia-Pacific Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 7.2.1.2.1 Asia-Pacific Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 7.2.1.2.2 Asia-Pacific Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 7.2.1.3 Asia-Pacific Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 7.3 Diagnosis Type Market
• 7.3.1 Overview
• 7.3.2 Asia-Pacific Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.3 Immunohistochemistry Market
• 7.3.3.1 Overview
• 7.3.3.2 Asia-Pacific Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.4 Stool Test Market
• 7.3.4.1 Overview
• 7.3.4.2 Asia-Pacific Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.5 Flexible Sigmoidoscopy Market
• 7.3.5.1 Overview
• 7.3.5.2 Asia-Pacific Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.6 Colonoscopy Market
• 7.3.6.1 Overview
• 7.3.6.2 Asia-Pacific Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.7 CEA Test Market
• 7.3.7.1 Overview
• 7.3.7.2 Asia-Pacific CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
• 7.3.8 Other Test Market
• 7.3.8.1 Overview
• 7.3.8.2 Asia-Pacific Other Test Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4 Therapy Type Market
• 7.4.1 Overview
• 7.4.2 Asia-Pacific Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
• 7.4.3 Chemotherapy Market
• 7.4.3.1 Overview
• 7.4.3.2 Asia-Pacific Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.3.3 Alkylating Agent Market
• 7.4.3.3.1 Overview
• 7.4.3.3.2 Asia-Pacific Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.3.4 Antimetabolites Market
• 7.4.3.4.1 Asia-Pacific Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.3.5 Others Market
• 7.4.3.5.1 Asia-Pacific Others Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.4 Immunotherapy Market
• 7.4.4.1 Overview
• 7.4.4.2 Asia-Pacific Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.4.3 Panitumumab Market
• 7.4.4.3.1 Overview
• 7.4.4.3.2 Asia-Pacific Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.4.4 Cetuximab Market
• 7.4.4.4.1 Overview
• 7.4.4.4.2 Asia-Pacific Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.4.5 Bevacizumab Market
• 7.4.4.5.1 Overview
• 7.4.4.5.2 Asia-Pacific Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.4.6 Others Market
• 7.4.4.6.1 Overview
• 7.4.4.6.2 Asia-Pacific Others Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.5 Chemoprotectant Market
• 7.4.5.1 Overview
• 7.4.5.2 Asia-Pacific Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
• 7.4.6 Others Market
• 7.4.6.1 Overview
• 7.4.6.2 Asia-Pacific Others Market Revenue and Forecast to 2027 (US$ Mn)
• 7.5 Imaging Type Market
• 7.5.1 Overview
• 7.5.2 Asia-Pacific Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
• 7.5.3 Computed Tomography (CT) Market
• 7.5.3.1 Overview
• 7.5.3.2 Asia-Pacific Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
• 7.5.4 Magnetic Resonance Imaging (MRI) Market
• 7.5.4.1 Overview
• 7.5.4.2 Asia-Pacific Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
• 7.5.5 Others Market
• 7.5.5.1 Overview
• 7.5.5.2 Asia-Pacific Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia-Pacific Colorectal Cancer Market Analysis- By End User

• 8.1 Overview
• 8.2 Asia-Pacific Colorectal Cancer Market, By End User 2018 & 2027 (%)
• 8.2.1 Asia-Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 8.3 Hospitals Market
• 8.3.1 Overview
• 8.3.2 Asia-Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
• 8.4 Diagnostic and Research Laboratories Market
• 8.4.1 Overview
• 8.4.2 Asia-Pacific Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9. Colorectal Cancer Market Revenue And Forecasts To 2027 - Geographical Analysis

• 9.1 Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027
• 9.1.1 Overview
• 9.1.2 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.3 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.3.1 Asia Pacific Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.3.2 Asia Pacific Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.3.2.1 Asia Pacific Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.3.2.2 Asia Pacific Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.3.3 Asia Pacific Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.4 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 9.1.5 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
• 9.1.6 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.6.1 China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.6.2 China Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.6.2.1 China Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.6.2.2 China Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.6.2.2.1 China Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.6.2.2.2 China Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.6.2.3 China Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.6.3 China Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 9.1.7 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.7.1 Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.7.2 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.7.2.1 Japan Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.7.2.2 Japan Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.7.2.2.1 Japan Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.7.2.2.2 Japan Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.7.2.3 Japan Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.7.3 Japan Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 9.1.8 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.8.1 India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.8.2 India Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.8.2.1 India Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.8.2.2 India Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.8.2.2.1 India Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.8.2.2.2 India Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.8.2.3 India Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.8.3 India Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 9.1.9 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.9.1 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.9.2 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.9.2.1 South Korea Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.9.2.2 South Korea Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.9.2.2.1 South Korea Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.9.2.2.2 South Korea Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.9.2.3 South Korea Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.9.3 South Korea Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
• 9.1.10 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.10.1 Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• 9.1.10.2 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• 9.1.10.2.1 Australia Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.10.2.2 Australia Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.10.2.2.1 Australia Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.10.2.2.2 Australia Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.10.2.3 Australia Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
• 9.1.10.3 Australia Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10. Asia-Pacific Colorectal Cancer Market- Industry Landscape

• 10.1 Overview
• 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
• 10.3 Organic Developments
• 10.3.1 Overview
• 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
• 10.4 Inorganic Developments
• 10.4.1 Overview
• 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019

11. Colorectal Cancer Market-Key Company Profiles

• 11.1 Epigenomics AG
• 11.1.1 Key Facts
• 11.1.2 Business Description
• 11.1.3 Financial Overview
• 11.1.4 Product Portfolio
• 11.1.5 SWOT Analysis
• 11.1.6 Key Developments
• 11.2 Novigenix SA
• 11.2.1 Key Facts
• 11.2.2 Business Description
• 11.2.3 Financial Overview
• 11.2.4 Product Portfolio
• 11.2.5 SWOT Analysis
• 11.2.6 Key Developments
• 11.3 Clinical Genomics Technologies Pty Ltd.
• 11.3.1 Key Facts
• 11.3.2 Business Description
• 11.3.3 Financial Overview
• 11.3.4 Product Portfolio
• 11.3.5 SWOT Analysis
• 11.3.6 Key Developments
• 11.4 EDP Biotech Corporation
• 11.4.1 Key Facts
• 11.4.2 Business Description
• 11.4.3 Financial Overview
• 11.4.4 Product Portfolio
• 11.4.5 SWOT Analysis
• 11.4.6 Key Developments
• 11.5 Volitionrx Limited
• 11.5.1 Key Facts
• 11.5.2 Business Description
• 11.5.3 Financial Overview
• 11.5.4 Product Portfolio
• 11.5.5 SWOT Analysis
• 11.5.6 Key Developments
• 11.6 Abbott Laboratories
• 11.6.1 Key Facts
• 11.6.2 Business Description
• 11.6.3 Financial Overview
• 11.6.4 Product Portfolio
• 11.6.5 SWOT Analysis
• 11.6.6 Key Developments
• 11.7 Amgen Inc.
• 11.7.1 Key Facts
• 11.7.2 Business Description
• 11.7.3 Financial Overview
• 11.7.4 Product Portfolio
• 11.7.5 Pipeline (Clinical Trials) Portfolio
• 11.7.6 SWOT Analysis
• 11.7.7 Key Developments
• 11.8 F. Hoffmann-La Roche AG
• 11.8.1 Key Facts
• 11.8.2 Business Description
• 11.8.3 Financial Overview
• 11.8.4 Product Portfolio
• 11.8.5 Pipeline (Clinical Trials) Portfolio
• 11.8.6 SWOT Analysis
• 11.8.7 Key Developments
• 11.9 Bruker Corporation
• 11.9.1 Key Facts
• 11.9.2 Business Description
• 11.9.3 Financial Overview
• 11.9.4 Product Portfolio
• 11.9.5 SWOT Analysis
• 11.9.6 Key Developments
• 11.10 Quest Diagnostics Incorporated
• 11.10.1 Key Facts
• 11.10.2 Business Description
• 11.10.3 Financial Overview
• 11.10.4 Product Portfolio
• 11.10.5 SWOT Analysis
• 11.10.6 Key Developments
• 11.11 Natera, Inc.
• 11.11.1 Key Facts
• 11.11.2 Business Description
• 11.11.3 Financial Overview
• 11.11.4 Product Portfolio
• 11.11.5 SWOT Analysis
• 11.11.6 Key Developments
• 11.12 Guardant Health, Inc.
• 11.12.1 Key Facts
• 11.12.2 Business Description
• 11.12.3 Financial Overview
• 11.12.4 Product Portfolio
• 11.12.5 SWOT Analysis
• 11.12.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

LIST OF TABLES

• Table 1. Asia-Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
• Table 2. Asia-Pacific Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 3. Asia-Pacific Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 4. Asia-Pacific Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 5. Asia-Pacific Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 6. Asia-Pacific Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 7. Asia-Pacific Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 8. Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 9. Asia Pacific Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 10. Asia Pacific Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 11. Asia Pacific Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 12. Asia Pacific Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 13. Asia Pacific Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 14. Asia Pacific Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 15. China Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 16. China Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 17. China Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 18. China Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 19. China Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 20. China Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 21. China Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 22. Japan Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 23. Japan Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 24. Japan Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 25. Japan Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 26. Japan Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 27. Japan Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 28. Japan Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 29. India Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 30. India Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 31. India Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 32. India Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 33. India Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 34. India Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 35. India Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 36. South Korea Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 37. South Korea Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 38. South Korea Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 39. South Korea Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 40. South Korea Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 41. South Korea Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 42. South Korea Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 43. Australia Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
• Table 44. Australia Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 45. Australia Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 46. Australia Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 47. Australia Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 48. Australia Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
• Table 49. Australia Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
• Table 50. Recent Organic Growth Strategies In The Colorectal Cancer Market
• Table 51. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
• Table 52. Glossary of Terms, Colorectal Cancer Market

LIST OF FIGURES

• Figure 1. Colorectal Cancer Market Segmentation
• Figure 2. Asia-Pacific Colorectal Cancer Market Overview
• Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
• Figure 4. China Is Expected To Show Remarkable Growth During The Forecast Period
• Figure 5. Asia-Pacific colorectal cancer Market- Leading Country Markets (US$ Mn)
• Figure 6. Asia-Pacific Colorectal Cancer Market, Industry Landscape
• Figure 7. Colorectal Cancer Market - Asia Pacific PEST Analysis
• Figure 8. Comparison of Brand - Name Drugs and Generic Drugs
• Figure 9. Colorectal Cancer Market Impact Analysis of Drivers and Restraints
• Figure 10. Asia-Pacific Colorectal Cancer Market - Revenue Forecasts and Analysis - 2018- 2027
• Figure 11. Market Positioning Of Key Player In Asia-Pacific Colorectal Cancer Market
• Figure 12. Asia-Pacific Colorectal Cancer Market, by Modality 2018 & 2027 (%)
• Figure 13. Asia-Pacific Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 14. Asia-Pacific Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 15. Asia-Pacific Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 16. Asia-Pacific Flexible Sigmoidoscopy Market Revenue and Forecasts to 2027 (US$ MN)
• Figure 17. Asia-Pacific Colonoscopy Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 18. Asia-Pacific CEA Test Market Revenue and Forecasts to 2027 (US$ MN)
• Figure 19. Asia-Pacific Other Test Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 20. Asia-Pacific Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 21. Asia-Pacific Chemotherapy Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 22. Asia-Pacific Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 23. Asia-Pacific Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 24. Asia-Pacific Others Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 25. Asia-Pacific Immunotherapy Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 26. Asia-Pacific Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 27. Asia-Pacific Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 28. Asia-Pacific Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 29. Asia-Pacific Others Market Revenue and Forecasts to 2027 (US$ MN)
• Figure 30. Asia-Pacific Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 31. Asia-Pacific Others Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 32. Asia-Pacific Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 33. Asia-Pacific Computed Tomography (CT) Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 34. Asia-Pacific Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts To 2027 (US$ MN)
• Figure 35. Asia-Pacific Others Market Revenue And Forecasts To 2027 (US$ MN)
• Figure 36. Asia-Pacific Colorectal Cancer Market, by End User 2018 & 2027 (%)
• Figure 37. Asia-Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 38. Asia-Pacific Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 39. Asia Pacific Colorectal Cancer Market Revenue Overview, By Country (2018) (US$ Mn)
• Figure 40. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 41. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
• Figure 42. China Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 43. Japan Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 44. India Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 45. South Korea Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 46. Australia Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
• Figure 47. Growth Strategies In The Colorectal Cancer Market, 2016-2019